PolyU collaborates with HKI Biotechnology to establish a joint laboratory for biotech innovation

The Hong Kong Polytechnic University (PolyU) and HKI Biotechnology (HKI) have collaborated to establish the "PolyU–HuiKang Joint Laboratory for Biotech Innovation" with the signing ceremony held on July 16, 2024.

The joint lab will leverage PolyU's expertise in life science and engineering, as well as HKI's strengths in peptide technology and drug development, to drive innovations in target discovery and drug development. Key focus areas for the joint lab include peptide drug discovery, high-throughput screening, and transforming "Human Lysozyme Eye Drops" research into new pharmaceuticals.

Through collaborative projects, shared resources, and talent development, the joint lab aims to open up new frontiers in biotechnology, and transform research outcomes into tangible health and wellbeing benefits for the community.